Influenza vaccination in solid-organ transplant recipients

Current Opinion in Organ Transplantation

Volumn 17, Issue 6, 2012, Pages 601-608

  Cordero, Elisa ^a   Manuel, Oriol ^b  

^a Instituto de Biomedicina de Sevilla   (Spain)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

antihuman leukocyte antigen antibodies; immunogenicity; mortality; prevention

Indexed keywords

HEMAGGLUTININ; INACTIVATED VACCINE; INFLUENZA VACCINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OSELTAMIVIR; TRIVALENT INACTIVATED VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ANTIBODY RESPONSE; ANTIVIRAL THERAPY; CLINICAL EFFECTIVENESS; DRUG CONTRAINDICATION; DRUG SAFETY; HEART TRANSPLANTATION; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; KIDNEY TRANSPLANTATION; LUNG TRANSPLANTATION; META ANALYSIS (TOPIC); MORBIDITY; MORTALITY; ORGAN TRANSPLANTATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SOLID ORGAN TRANSPLANTATION; SYSTEMATIC REVIEW (TOPIC); THERAPY DELAY; TREATMENT RESPONSE; VIRUS MUTATION;

ANIMALS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLUENZA VACCINES; INFLUENZA, HUMAN; ORGAN TRANSPLANTATION; TRANSPLANTATION; VACCINATION;

EID: 84870245829     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283592622     Document Type: Review

References (77)

1. Neuzil KM, Reed GW, Mitchel EF Jr, Griffin MR. Influenza-associated morbidity and mortality in young and middle-aged women. JAMA 1999; 281:901-907. (Pubitemid 29124633)
2. Kumar D, Blumberg EA, Danziger-Isakov L, et al. Influenza vaccination in the organ transplant recipient: review and summary recommendations. Am J Transplant 2011; 11:2020-2030.
3. Cordero E, Perez-Romero P, Moreno A, et al. Pandemic influenza A(H1N1) virus infection in solid organ transplant recipients: impact of viral and nonviral co-infection. Clin Microbiol Infect 2012; 18:67-73.
4. Kumar D, Michaels MG, Morris MI, et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 2010; 10:521-526.
5. Ng BJ, Glanville AR, Snell G, et al. The impact of pandemic influenza A H1N1 2009 on Australian lung transplant recipients. Am J Transplant 2011; 11:568-574.
6. Brakemeier S, Schweiger B, Lachmann N, et al. Immune response to an adjuvanted influenza A H1N1 vaccine (Pandemrix) in renal transplant recipients. Nephrol Dial Transplant 2012; 27:423-428.
7. Cordero E, Perez-Ordonez A, Aydillo TA, et al. Therapy with m-TOR inhibitors decreases the response to the pandemic influenza A H1N1 vaccine in solid organ transplant recipients. Am J Transplant 2011; 11:2205-2213.
8. Manuel O, Pascual M, Hoschler K, et al. Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients. Clin Infect Dis 2011; 52:248-256.
9. Siegrist CA, Ambrosioni J, Bel M, et al. Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccine. Antivir Ther 2012; 17:893-903.
10. Bogoch II, Andrews JR, Hohmann EL, et al. Pandemic H1N1 influenza infection in adult transplant recipients. Transplantation 2011; 91:e80-e81.
11. Crockett F, Mal H, Amazzough K, et al. H1N1 (2009) influenza A infection in transplant recipient patients: a comparative study versus nontransplanted patients. Rev Pneumol Clin 2011; 67:199-208.
12. Danziger-Isakov LA, Husain S, Mooney ML, Hannan MM. The novel 2009 H1N1 influenza virus pandemic: unique considerations for programs in cardiothoracic transplantation. J Heart Lung Transplant 2009; 28:1341-1347.
13. Fox BD, Raviv Y, Rozengarten D, et al. Pandemic influenza (H1N1): impact on lung transplant recipients and candidates. J Heart Lung Transplant 2010; 29:1034-1038.
14. Freitas TV, Ono G, Correa L, et al. Clinical manifestations and evolution of infection by influenza A (H1N1) in kidney transplant recipients. J Bras Nefrol 2011; 33:136-141.
15. Kumar D, Morris MI, Kotton CN, et al. Guidance on novel influenza A/H1N1 in solid organ transplant recipients. Am J Transplant 2010; 10:18-25.
16. Low CY, Kee T, Chan KP, et al. Pandemic (H1N1)2009 infection in adult solid organ transplant recipients in Singapore. Transplantation 2010; 90:1016-1021.
17. Minnema BJ, Patel M, Rotstein C, et al. Comparison of hospitalized solid organ transplant recipients and nonimmunocompromised patients with pandemic H1N1 infection: a retrospective cohort study. Transplantation 2011; 92:230-234.
18. Ridao-Cano N, Sanchez-Fructuoso AI, Rodriguez-Moreno A, Barrientos A. H1N1 2009 influenza in kidney transplant patients. Transplantation 2010; 90:224-225.
19. Smud A, Nagel CB, Madsen E, et al. Pandemic influenza A/H1N1 virus infection in solid organ transplant recipients: a multicenter study. Transplantation 2010; 90:1458-1462.
20. Vilchez RA, McCurry K, Dauber J, et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002; 2:287-291. (Pubitemid 36330248)
21. Kunisaki KM, Janoff EN. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 2009; 9:493-504.
22. Seville MT, Blair JE, Vikram HR, Kusne S. 2009 H1N1 influenza in hospitalized transplant recipients. Transplantation 2010; 90:571-574.
23. Troppmann C, Cohen S, de Mattos A, Perez R. Rapidly progressive lethal infection with novel influenza A (H1N1) 2009 virus in a kidney recipient: a cautionary tale. Transplantation 2010; 89:369-370.
24. Watcharananan SP, Suwatanapongched T, Wacharawanichkul P, et al. Influenza A/H1N1 2009 pneumonia in kidney transplant recipients: characteristics and outcomes following high-dose oseltamivir exposure. Transpl Infect Dis 2010; 12:127-131.
25. Centers for Disease Control and Prevention. Patients hospitalized with 2009 pandemic influenza A (H1N1): New York City, May 2009. MMWR Morb Mortal Wkly Rep 2010; 58:1436-1440.
26. Cao B, Li XW, Mao Y, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009; 361:2507-2517.
27. Cordero E, Aydillo T, Farinas MC, et al. Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection. Eur J Clin Microbiol Infect Dis 2012; 31:547-556.
28. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenzainthe United States, April-June 2009. N Engl J Med 2009; 361:1935-1944.
29. Kumar A, Zarychanski R, Cook DJ, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009; 302:1872-1879.
30. Lee N, Choi KW, Chan PK, et al. Outcomes of adults hospitalised with severe influenza. Thorax 2010; 65:510-515.
31. Lee N, Cockram CS, Chan PK, et al. Antiviral treatment for patients hospitalized with severe influenza infection may affect clinical outcomes. Clin Infect Dis 2008; 46:1323-1324. (Pubitemid 351589924)
32. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009; 361:680-689.
33. Viasus D, Pano-Pardo JR, Pachon J, et al. Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. Clin Microbiol Infect 2010; 17:738-746.
34. Mason DP, Murthy SC, Yun JJ, et al. Lung transplantation in a recipient with novel 2009 H1N1 influenza: lessons learned. Thorac Cardiovasc Surg 2011; 59:126-127.
35. Vilchez R, McCurry K, Dauber J, et al. Influenza and parainfluenza respiratory viral infection requiring admission in adult lung transplant recipients. Transplantation 2002; 73:1075-1078. (Pubitemid 34415437)
36. Stucchi RS, Boin IF, Angerami RN, et al. Correlations between A/H1N1 influenza and acute cellular rejection in liver transplantation patients. Transplant Proc 2010; 42:4184-4186.
37. Vistoli F, Focosi D, De Donno M, et al. Pancreas rejection after pandemic influenza virus A(H1N1) vaccination or infection: a report of two cases. Transpl Int 2011; 24:e28-e29.
38. Zapata R, Uribe M, Martinez W, et al. Severe novel H1N1 influenza A infection in the immediate postoperative period of a liver transplant patient. Liver Transpl 2010; 16:447-452.
39. Campbell A, Rodin R, Kropp R, et al. Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. CMAJ 2010; 182:349-355.
40. Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011; 60:1128-1132.
41. Belshe RB, Ambrose CS, Yi T. Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age. Vaccine 2008; 26 (Suppl 4):D10-D16.
42. Plotkin JB, Dushoff J. Codon bias and frequency-dependent selection on the hemagglutinin epitopes of influenza A virus. Proc Natl Acad Sci U S A 2003; 100:7152-7157. (Pubitemid 36706408)
43. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:36-44.
44. Jefferson T, Rivetti A, Di Pietrantonj C, et al. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2010:CD001269.
45. Jefferson T, Di Pietrantonj C, Al-Ansary LA, et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010:CD004876.
46. Beck CR, McKenzie BC, Hashim AB, et al. Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective. PLoS One 2011; 6:e29249.
47. Hobson D, Curry RL, Beare AS, Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hygiene 1972; 70:767-777.
48. Broeders NE, Hombrouck A, Lemy A, et al. Influenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort study. Clin J Am Soc Nephrol: CJASN 2011; 6:2573-2578.
49. Crespo M, Collado S, Mir M, et al. Efficacy of influenza A H1N1/2009 vaccine in hemodialysis and kidney transplant patients. Clin J Am Soc Nephrol: CJASN 2011; 6:2208-2214.
50. Felldin M, Studahl M, Svennerholm B, Friman V. The antibody response to pandemic H1N1 2009 influenza vaccine in adult organ transplant patients. Transpl Int 2012; 25:166-171.
51. Lagler H, Wenisch JM, Tobudic S, et al. Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, nonadjuvanted, whole-virion vaccination. Vaccine 2011; 29:6888-6893.
52. Meyer S, Adam M, Schweiger B, et al. Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients. Transplantation 2011; 91:1031-1035.
53. Miraglia JL, Abdala E, Hoff PM, et al. Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent nonadjuvanted vaccine in elderly and immunocompromised patients. PloS One 2011; 6:e27214.
54. Mulley WR, Visvanathan K, Hurt AC, et al. Mycophenolate and lower graft function reduce the seroresponse of kidney transplant recipients to pandemic H1N1 vaccination. Kidney Int 2012; 82:212-219.
55. Manuel O, Humar A, Berutto C, et al. Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients. J Heart Lung Transplant 2011; 30:679-684.
56. Manuel O, Humar A, Chen MH, et al. Immunogenicity and safety of an intradermal boosting strategy for vaccination against influenza in lung transplant recipients. Am J Transplant 2007; 7:2567-2572. (Pubitemid 47561624)
57. Mazzone PJ, Mossad SB, Mawhorter SD, et al. The humoral immune response to influenza vaccination in lung transplant patients. Eur Respir J 2001; 18:971-976. (Pubitemid 34092871)
58. Scharpé J, Evenepoel P, Maes B, et al. Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant 2008; 8:332-337.
59. Salles MJ, Sens YA, Boas LS, Machado CM. Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immuno-suppressive drugs. Clin Transplant 2010; 24:E17-E23.
60. Orcurto A, Pascual M, Hoschler K, et al. Impact of anti-T cell therapy in the immunogenicity of seasonal influenza vaccine in kidney transplants recipients. Transplantation 2012. Epub ahead of print.
61. Blumberg EA, Fitzpatrick J, Stutman PC, et al. Safety of influenza vaccine in heart transplant recipients. J Heart Lung Transplant 1998; 17:1075-1080. (Pubitemid 28547275)
62. Candon S, Thervet E, Lebon P, et al. Humoral and cellular immune responses after influenza vaccination in kidney transplant recipients. Am J Transplant 2009; 9:2346-2354.
63. Katerinis I, Hadaya K, Duquesnoy R, et al. De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients. Am J Transplant 2011; 11:1727-1733.
64. Schaffer SA, Husain S, Delgado DH, et al. Impact of adjuvanted H1N1 vaccine on cell-mediated rejection in heart transplant recipients. Am J Transplant 2011; 11:2751-2754.
65. Kumar D, Campbell P, Humar A. Donor-specific alloantibody upregulation after influenza vaccination in transplant recipients. Am J Transplant 2011; 11:2538-2540.
66. Lawal A, Basler C, Branch A, et al. Influenza vaccination in orthotopic liver transplant recipients: absence of post administration ALT elevation. Am J Transplant 2004; 4:1805-1809. (Pubitemid 39434441)
67. Birdwell KA, Ikizler MR, Sannella EC, et al. Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study. Am J Kidney Dis 2009; 54:112-121.
68. Cordero E, Aydillo TA, Perez-Ordonez A, et al. Deficient long-term response to pandemic vaccine results in an insufficient antibody response to seasonal influenza vaccination in solid organ transplant recipients. Transplantation 2012; 93:847-854.
69. Blumberg EA, Albano C, Pruett T, et al. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis 1996; 22:295-302. (Pubitemid 26056158)
70. Soesman NM, Rimmelzwaan GF, Nieuwkoop NJ, et al. Efficacy of influenza vaccination in adult liver transplant recipients. J Med Virol 2000; 61:85-93. (Pubitemid 30191231)
71. Falsey AR, Treanor JJ, Tornieporth N, et al. Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standarddose influenza vaccine in adults 65 years of age and older. J Infect Dis 2009; 200:172-180.
72. Clark TW, Pareek M, Hoschler K, et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med 2009; 361:2424-2435.
73. Greenberg ME, Lai MH, Hartel GF, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009; 361:2405-2413.
74. Waddington CS, Walker WT, Oeser C, et al. Safety and immunogenicity of AS03B adjuvanted split virion versus nonadjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study. BMJ 2010; 340:c2649.
75. Kenney RT, Frech SA, Muenz LR, et al. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 2004; 351:2295-2301. (Pubitemid 39552745)
76. Morelon E, Pouteil NC, Daoud S, et al. Immunogenicity and safety ofintradermal influenza vaccination in renal transplant patients who were nonresponders to conventional influenza vaccination. Vaccine 2010; 28:6885-6890.
77. Baluch A, Humar A, Egli A, et al. A randomized controlled trial of high-dose intradermal vs. standard intramuscular influenza vaccine in solid organ transplant recipients. Am J Transplant 2012; 12 (s3):53-54.